These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 35006282)

  • 1. Immunoinformatics prediction of potential immunodominant epitopes from human coronaviruses and association with autoimmunity.
    Mathew S; Fakhroo AD; Smatti M; Al Thani AA; Yassine HM
    Immunogenetics; 2022 Apr; 74(2):213-229. PubMed ID: 35006282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunopeptidome profiling of human coronavirus OC43-infected cells identifies CD4 T-cell epitopes specific to seasonal coronaviruses or cross-reactive with SARS-CoV-2.
    Becerra-Artiles A; Nanaware PP; Muneeruddin K; Weaver GC; Shaffer SA; Calvo-Calle JM; Stern LJ
    PLoS Pathog; 2023 Jul; 19(7):e1011032. PubMed ID: 37498934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Novel Candidate CD8
    Pushpakumara PD; Madhusanka D; Dhanasekara S; Jeewandara C; Ogg GS; Malavige GN
    Viruses; 2021 May; 13(6):. PubMed ID: 34073934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunopeptidome profiling of human coronavirus OC43-infected cells identifies CD4 T cell epitopes specific to seasonal coronaviruses or cross-reactive with SARS-CoV-2.
    Becerra-Artiles A; Nanaware PP; Muneeruddin K; Weaver GC; Shaffer SA; Calvo-Calle JM; Stern LJ
    bioRxiv; 2022 Dec; ():. PubMed ID: 36482973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-Recognition of SARS-CoV-2 B-Cell Epitopes with Other Betacoronavirus Nucleoproteins.
    Tajuelo A; López-Siles M; Más V; Pérez-Romero P; Aguado JM; Briz V; McConnell MJ; Martín-Galiano AJ; López D
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune profiling of SARS-CoV-2 epitopes in asymptomatic and symptomatic pediatric and adult patients.
    Tornesello AL; Botti C; Micillo A; Labonia F; Arpino S; Isgrò MA; Meola S; Russo L; Cavalcanti E; Sale S; Nicastro C; Atripaldi L; Starita N; Cerasuolo A; Reimer U; Holenya P; Buonaguro L; Buonaguro FM; Tornesello ML
    J Transl Med; 2023 Feb; 21(1):123. PubMed ID: 36788606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoinformatics Identification of the Conserved and Cross-Reactive T-Cell Epitopes of SARS-CoV-2 with Human Common Cold Coronaviruses, SARS-CoV, MERS-CoV and Live Attenuated Vaccines Presented by HLA Alleles of Indonesian Population.
    Gustiananda M; Julietta V; Hermawan A; Febriana GG; Hermantara R; Kristiani L; Sidhartha E; Sutejo R; Agustriawan D; Andarini S; Parikesit AA
    Viruses; 2022 Oct; 14(11):. PubMed ID: 36366426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prospect of universal coronavirus immunity: characterization of reciprocal and non-reciprocal T cell responses against SARS-CoV2 and common human coronaviruses.
    Soni MK; Migliori E; Fu J; Assal A; Chan HT; Pan J; Khatiwada P; Ciubotariu R; May MS; Pereira MR; De Giorgi V; Sykes M; Mapara MY; Muranski PJ
    Front Immunol; 2023; 14():1212203. PubMed ID: 37901229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential CD8+ T Cell Cross-Reactivity Against SARS-CoV-2 Conferred by Other Coronavirus Strains.
    Lee CH; Pinho MP; Buckley PR; Woodhouse IB; Ogg G; Simmons A; Napolitani G; Koohy H
    Front Immunol; 2020; 11():579480. PubMed ID: 33250893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 and other human coronaviruses: Mapping of protease recognition sites, antigenic variation of spike protein and their grouping through molecular phylogenetics.
    Chakraborty C; Sharma AR; Bhattacharya M; Saha RP; Ghosh S; Biswas S; Samanta S; Sharma G; Agoramoorthy G; Lee SS
    Infect Genet Evol; 2021 Apr; 89():104729. PubMed ID: 33497837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2-Seronegative Subjects Target CTL Epitopes in the SARS-CoV-2 Nucleoprotein Cross-Reactive to Common Cold Coronaviruses.
    Schmidt KG; Nganou-Makamdop K; Tenbusch M; El Kenz B; Maier C; Lapuente D; Überla K; Spriewald B; Bergmann S; Harrer EG; Harrer T
    Front Immunol; 2021; 12():627568. PubMed ID: 33995351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An overview on the seven pathogenic human coronaviruses.
    Kesheh MM; Hosseini P; Soltani S; Zandi M
    Rev Med Virol; 2022 Mar; 32(2):e2282. PubMed ID: 34339073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD8
    Lineburg KE; Grant EJ; Swaminathan S; Chatzileontiadou DSM; Szeto C; Sloane H; Panikkar A; Raju J; Crooks P; Rehan S; Nguyen AT; Lekieffre L; Neller MA; Tong ZWM; Jayasinghe D; Chew KY; Lobos CA; Halim H; Burrows JM; Riboldi-Tunnicliffe A; Chen W; D'Orsogna L; Khanna R; Short KR; Smith C; Gras S
    Immunity; 2021 May; 54(5):1055-1065.e5. PubMed ID: 33945786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of B-Cell Linear Epitopes in the Nucleocapsid (N) Protein B-Cell Linear Epitopes Conserved among the Main SARS-CoV-2 Variants.
    Rodrigues-da-Silva RN; Conte FP; da Silva G; Carneiro-Alencar AL; Gomes PR; Kuriyama SN; Neto AAF; Lima-Junior JC
    Viruses; 2023 Apr; 15(4):. PubMed ID: 37112903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Revelation of Potent Epitopes Present in Unannotated ORF Antigens of SARS-CoV-2 for Epitope-Based Polyvalent Vaccine Design Using Immunoinformatics Approach.
    Uttamrao PP; Sathyaseelan C; Patro LPP; Rathinavelan T
    Front Immunol; 2021; 12():692937. PubMed ID: 34497604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Broadly recognized, cross-reactive SARS-CoV-2 CD4 T cell epitopes are highly conserved across human coronaviruses and presented by common HLA alleles.
    Becerra-Artiles A; Calvo-Calle JM; Co MD; Nanaware PP; Cruz J; Weaver GC; Lu L; Forconi C; Finberg RW; Moormann AM; Stern LJ
    Cell Rep; 2022 Jun; 39(11):110952. PubMed ID: 35675811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-reactive and mono-reactive SARS-CoV-2 CD4+ T cells in prepandemic and COVID-19 convalescent individuals.
    Johansson AM; Malhotra U; Kim YG; Gomez R; Krist MP; Wald A; Koelle DM; Kwok WW
    PLoS Pathog; 2021 Dec; 17(12):e1010203. PubMed ID: 34965282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping SARS-CoV-2 Antibody Epitopes in COVID-19 Patients with a Multi-Coronavirus Protein Microarray.
    Camerini D; Randall AZ; Trappl-Kimmons K; Oberai A; Hung C; Edgar J; Shandling A; Huynh V; Teng AA; Hermanson G; Pablo JV; Stumpf MM; Lester SN; Harcourt J; Tamin A; Rasheed M; Thornburg NJ; Satheshkumar PS; Liang X; Kennedy RB; Yee A; Townsend M; Campo JJ
    Microbiol Spectr; 2021 Oct; 9(2):e0141621. PubMed ID: 34704808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epitope-based peptide vaccine design and elucidation of novel compounds against 3C like protein of SARS-CoV-2.
    Sajid M; Marriam S; Mukhtar H; Sohail S; Sajid M; Sehgal SA
    PLoS One; 2022; 17(3):e0264700. PubMed ID: 35324925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioinformatics analysis of epitope-based vaccine design against the novel SARS-CoV-2.
    Chen HZ; Tang LL; Yu XL; Zhou J; Chang YF; Wu X
    Infect Dis Poverty; 2020 Jul; 9(1):88. PubMed ID: 32741372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.